Dexpramipexole is also under investigation as a potential solution for those suffering with hypereosnophilic syndrome
Dexpramipexole is also under investigation as a potential solution for those suffering with hypereosnophilic syndrome
Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.